BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2521557)

  • 1. Patch testing with carbamazepine: reinduction of an exfoliative dermatitis.
    Vaillant L; Camenen I; Lorette G
    Arch Dermatol; 1989 Feb; 125(2):299. PubMed ID: 2521557
    [No Abstract]   [Full Text] [Related]  

  • 2. Patch testing in ocular drug allergies.
    Marsh RJ; Towns S; Evans KF
    Trans Ophthalmol Soc U K (1962); 1978; 98(2):278-80. PubMed ID: 155908
    [No Abstract]   [Full Text] [Related]  

  • 3. Carbamazepine induced DRESS syndrome.
    Chauhan A; Anand S; Thomas S; Subramanya HC; Pradhan G
    J Assoc Physicians India; 2010 Oct; 58():634-6. PubMed ID: 21510116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patch testing in cutaneous reactions caused by carbamazepine.
    Alanko K
    Contact Dermatitis; 1993 Nov; 29(5):254-7. PubMed ID: 8112065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamazepine induced erythroderma with systemic lymphadenopathy.
    Okuyama R; Ichinohasama R; Tagami H
    J Dermatol; 1996 Jul; 23(7):489-94. PubMed ID: 8772031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of type IV hypersensitivity to topiramate and carbamazepine.
    Schiavino D; Nucera E; Buonomo A; Musumeci S; Pollastrini E; Roncallo C; Lombardo C; Alonzi C; Pecora V; Corradini C; De Pasquale T; Patriarca G
    Contact Dermatitis; 2005 Mar; 52(3):161-2. PubMed ID: 15811034
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbamazepine induced eczematous eruption-clinically resembling atopic dermatitis.
    Ozkaya-Bayazit E; Güngör H
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):182-3. PubMed ID: 10343956
    [No Abstract]   [Full Text] [Related]  

  • 8. DRESS syndrome associated with carbamazepine and phenytoin.
    Allam JP; Paus T; Reichel C; Bieber T; Novak N
    Eur J Dermatol; 2004; 14(5):339-42. PubMed ID: 15358574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Photodiagnosis: the modified intradermal test in comparison with other procedures for the detection of phototoxic and photo-allergic drug reactions].
    Schauder S
    Z Hautkr; 1990 Mar; 65(3):247-8, 251-2. PubMed ID: 2140221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patch test diagnosis of carbamazepine sensitivity?
    Rodriguez Mosquera M; Iglesias A; Sáez A; Vidal C
    Contact Dermatitis; 1991 Aug; 25(2):137-8. PubMed ID: 1834428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Erythroderma caused by carbamazepine. Diagnosis with skin patch].
    Blasco Sarramían A; Pinilla Moraza J; Atares Pueyo MB; Lobera Labairu T; Izquier-Do Cuartero MA; San Román Lazcano FJ
    An Med Interna; 1993 Jul; 10(7):341-2. PubMed ID: 8218768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Skin tests in the study of drug eruptions with suspected immuno-allergic mechanism].
    Barbaud A; Béné MC; Faure G; Schmutz JL
    Bull Acad Natl Med; 2000; 184(4):775-91. PubMed ID: 10989563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patch testing for contact dermatitis.
    Treadgold A
    Nursing (Lond); 1983 Jan; 2(9):255-8. PubMed ID: 6554529
    [No Abstract]   [Full Text] [Related]  

  • 14. Patch test diagnosis of exfoliative dermatitis due to carbamazepine.
    Camarasa JG
    Contact Dermatitis; 1985 Jan; 12(1):49. PubMed ID: 3156718
    [No Abstract]   [Full Text] [Related]  

  • 15. Patch testing with carbamazepine and its main metabolite carbamazepine epoxide in cutaneous adverse drug reactions to carbamazepine.
    Lee AY; Choi J; Chey WY
    Contact Dermatitis; 2003 Mar; 48(3):137-9. PubMed ID: 12755726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patch testing.
    McGillis ST; Burrall BA; Huntley AC
    Clin Rev Allergy; 1989; 7(4):441-53. PubMed ID: 2691044
    [No Abstract]   [Full Text] [Related]  

  • 17. Patch testing in the detection of cutaneous reactions caused by carbamazepine.
    Liao HT; Hung KL; Wang CF; Chen WC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(5):365-9. PubMed ID: 9401180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of skin tests to prove drug hypersensitivity.
    Lammintausta K; Kortekangas-Savolainen O
    Br J Dermatol; 2005 May; 152(5):968-74. PubMed ID: 15888154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Patch testing with nickel compounds].
    Hums R; Müller S
    Dermatol Monatsschr; 1988; 174(12):730-5. PubMed ID: 3215375
    [No Abstract]   [Full Text] [Related]  

  • 20. Carbamazepine and patch testing.
    Motley RJ; Reynolds AJ
    Contact Dermatitis; 1989 Oct; 21(4):285-6. PubMed ID: 2598661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.